vs
Side-by-side financial comparison of ASHFORD HOSPITALITY TRUST INC (AHT) and AVANOS MEDICAL, INC. (AVNS). Click either name above to swap in a different company.
ASHFORD HOSPITALITY TRUST INC is the larger business by last-quarter revenue ($259.0M vs $180.9M, roughly 1.4× AVANOS MEDICAL, INC.). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -26.8%, a 26.1% gap on every dollar of revenue. On growth, AVANOS MEDICAL, INC. posted the faster year-over-year revenue change (0.7% vs -6.0%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $-86.8M). Over the past eight quarters, AVANOS MEDICAL, INC.'s revenue compounded faster (4.4% CAGR vs -7.7%).
Ashford Hospitality Trust Inc is a U.S.-headquartered real estate investment trust focused on upper-upscale full-service hotel properties across key U.S. urban, suburban and resort markets. Its portfolio holds assets under top global hospitality brands, serving business and leisure travelers, with a focus on long-term value growth and stable shareholder returns.
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
AHT vs AVNS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $259.0M | $180.9M |
| Net Profit | $-69.3M | $-1.3M |
| Gross Margin | — | 47.5% |
| Operating Margin | -2.6% | 1.4% |
| Net Margin | -26.8% | -0.7% |
| Revenue YoY | -6.0% | 0.7% |
| Net Profit YoY | 44.2% | 99.7% |
| EPS (diluted) | $-12.85 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $259.0M | $180.9M | ||
| Q3 25 | $266.1M | $177.8M | ||
| Q2 25 | $302.0M | $175.0M | ||
| Q1 25 | $277.4M | $167.5M | ||
| Q4 24 | $275.5M | $179.6M | ||
| Q3 24 | $276.6M | $170.4M | ||
| Q2 24 | $316.5M | $171.7M | ||
| Q1 24 | $303.9M | $166.1M |
| Q4 25 | $-69.3M | $-1.3M | ||
| Q3 25 | $-60.1M | $-1.4M | ||
| Q2 25 | $-30.4M | $-76.8M | ||
| Q1 25 | $-20.0M | $6.6M | ||
| Q4 24 | $-124.2M | $-397.3M | ||
| Q3 24 | $-57.9M | $4.3M | ||
| Q2 24 | $50.3M | $1.8M | ||
| Q1 24 | $71.6M | $-900.0K |
| Q4 25 | — | 47.5% | ||
| Q3 25 | — | 48.4% | ||
| Q2 25 | — | 52.6% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 54.6% | ||
| Q3 24 | — | 54.5% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 57.1% |
| Q4 25 | -2.6% | 1.4% | ||
| Q3 25 | 4.6% | 0.1% | ||
| Q2 25 | 16.3% | -42.6% | ||
| Q1 25 | 22.2% | 6.1% | ||
| Q4 24 | -17.8% | -233.0% | ||
| Q3 24 | 7.3% | 7.0% | ||
| Q2 24 | 42.8% | 3.7% | ||
| Q1 24 | 50.2% | 2.4% |
| Q4 25 | -26.8% | -0.7% | ||
| Q3 25 | -22.6% | -0.8% | ||
| Q2 25 | -10.1% | -43.9% | ||
| Q1 25 | -7.2% | 3.9% | ||
| Q4 24 | -45.1% | -221.2% | ||
| Q3 24 | -20.9% | 2.5% | ||
| Q2 24 | 15.9% | 1.0% | ||
| Q1 24 | 23.5% | -0.5% |
| Q4 25 | $-12.85 | $-0.02 | ||
| Q3 25 | $-11.35 | $-0.03 | ||
| Q2 25 | $-6.88 | $-1.66 | ||
| Q1 25 | $-4.91 | $0.14 | ||
| Q4 24 | $-13.64 | $-8.64 | ||
| Q3 24 | $-12.39 | $0.09 | ||
| Q2 24 | $2.50 | $0.04 | ||
| Q1 24 | $5.99 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $66.1M | $89.8M |
| Total DebtLower is stronger | $2.5B | $90.3M |
| Stockholders' EquityBook value | $-626.4M | $778.2M |
| Total Assets | $2.8B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.1M | $89.8M | ||
| Q3 25 | $81.9M | $70.5M | ||
| Q2 25 | $100.0M | $90.3M | ||
| Q1 25 | $85.8M | $97.0M | ||
| Q4 24 | $112.9M | $107.7M | ||
| Q3 24 | $119.7M | $89.0M | ||
| Q2 24 | $121.8M | $92.2M | ||
| Q1 24 | $111.1M | $75.8M |
| Q4 25 | $2.5B | $90.3M | ||
| Q3 25 | $2.6B | $93.4M | ||
| Q2 25 | $2.6B | $95.7M | ||
| Q1 25 | $2.7B | $98.0M | ||
| Q4 24 | $2.6B | $125.3M | ||
| Q3 24 | $2.7B | $152.6M | ||
| Q2 24 | $2.8B | $164.9M | ||
| Q1 24 | $2.9B | $167.2M |
| Q4 25 | $-626.4M | $778.2M | ||
| Q3 25 | $-548.7M | $778.0M | ||
| Q2 25 | $-485.5M | $776.3M | ||
| Q1 25 | $-446.1M | $839.4M | ||
| Q4 24 | $-419.2M | $828.5M | ||
| Q3 24 | $-288.4M | $1.2B | ||
| Q2 24 | $-225.9M | $1.2B | ||
| Q1 24 | $-276.8M | $1.2B |
| Q4 25 | $2.8B | $1.1B | ||
| Q3 25 | $3.0B | $1.1B | ||
| Q2 25 | $3.1B | $1.0B | ||
| Q1 25 | $3.1B | $1.1B | ||
| Q4 24 | $3.2B | $1.2B | ||
| Q3 24 | $3.3B | $1.7B | ||
| Q2 24 | $3.3B | $1.7B | ||
| Q1 24 | $3.5B | $1.7B |
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.13× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $28.2M |
| Free Cash FlowOCF − Capex | $-86.8M | $21.3M |
| FCF MarginFCF / Revenue | -33.5% | 11.8% |
| Capex IntensityCapex / Revenue | 27.5% | 3.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-135.5M | $43.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.7M | $28.2M | ||
| Q3 25 | $5.5M | $14.0M | ||
| Q2 25 | $16.3M | $6.8M | ||
| Q1 25 | $-25.0M | $25.7M | ||
| Q4 24 | $-23.6M | $57.9M | ||
| Q3 24 | $795.0K | $23.0M | ||
| Q2 24 | $8.0M | $27.8M | ||
| Q1 24 | $-46.5M | $-8.0M |
| Q4 25 | $-86.8M | $21.3M | ||
| Q3 25 | $-226.0K | $7.0M | ||
| Q2 25 | $-3.6M | $-4.2M | ||
| Q1 25 | $-44.8M | $19.0M | ||
| Q4 24 | $-131.6M | $53.1M | ||
| Q3 24 | $-21.8M | $20.0M | ||
| Q2 24 | $-22.9M | $21.9M | ||
| Q1 24 | $-80.4M | $-12.1M |
| Q4 25 | -33.5% | 11.8% | ||
| Q3 25 | -0.1% | 3.9% | ||
| Q2 25 | -1.2% | -2.4% | ||
| Q1 25 | -16.2% | 11.3% | ||
| Q4 24 | -47.8% | 29.6% | ||
| Q3 24 | -7.9% | 11.7% | ||
| Q2 24 | -7.2% | 12.8% | ||
| Q1 24 | -26.5% | -7.3% |
| Q4 25 | 27.5% | 3.8% | ||
| Q3 25 | 2.1% | 3.9% | ||
| Q2 25 | 6.6% | 6.3% | ||
| Q1 25 | 7.2% | 4.0% | ||
| Q4 24 | 39.2% | 2.7% | ||
| Q3 24 | 8.2% | 1.8% | ||
| Q2 24 | 9.8% | 3.4% | ||
| Q1 24 | 11.2% | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.89× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.35× | ||
| Q2 24 | 0.16× | 15.44× | ||
| Q1 24 | -0.65× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHT
| Occupancy | $190.2M | 73% |
| Food And Beverage | $51.8M | 20% |
| Hotel Other | $16.6M | 6% |
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
